Skip to main content
Source: https://bisresearch.com/industry-report/viral-non-viral-vector-manufacturing-market.html

Category: Business

The advent of advanced therapies, including gene therapy and cell therapy, which employ the use of vectors, has created a huge impact in the field of medicine in the past few decades. Therapies that require genetic modification, including the introduction of therapeutic deoxyribonucleic acid (DNA)/gene into a patient's body or cell, demonstrated tremendous potential for treating several fatal diseases, including cancer, Alzheimer's disease, Parkinson's disease, and rheumatoid arthritis, among others. Promising results displayed by these vector-based therapies in several preclinical and clinical studies have further emphasized the development and standardization of various viral and non-viral vectors to address unmet medical needs. The global viral and non-viral vector manufacturing market was valued at $1.50 billion in 2020 and is expected to reach $27.03 billion by 2031, witnessing a CAGR of 18.54% during the forecast period 2021-2031.

You may like

Matte Visiting Cards

#MatteVisitingCards, #MatteFinish, #ElegantBusinessCards, #SmoothTouch, #PremiumQuality, #CustomMatteCards, #ModernDesign

Glossy Business Cards

#GlossyBusinessCards, #HighGlossFinish, #ShinyBusinessCards, #LuxuryVisitingCards, #PremiumPrinting, #ProfessionalDesign, #VibrantColors

Eco-Friendly Business Card

#EcoFriendlyBusinessCards, #SustainableDesign, #RecycledPaperCards, #GreenPrinting, #EcoBranding, #BiodegradableCards, #EnvironmentFriendly

Comments

Verapamil hydrochloride 40 mg EN LIGNE EN LUXEMBOURG VENTE ACHAT SANS ORDONNANCE ~~ Verapamil hydrochloride 40mg LIVRAISON 72H BELGIQUE MOINS CHER <a href=http://www.safeshopping.biz/go.php?...

Read more